NIAEM

National Independent Academy of Evidence-Based Medicine

Registry of prospective clinical studies

Public registration of plans for studies involving people, including the examination of their materials and data in the interest of health, is a widely recognized standard of scientific ethics.

Our results and achievements

600 000+

publication views of all time

10 000+

subscribers across various platforms

400+

publications on evidence-based medicine

300+

channels have cited NIAEM

NIAEM's goal

NIAEM helps physicians register their study

01

Registry of prospective clinical studies

A Russian-language platform where Russian researchers can register their work without language barriers.

02

Guide to using the registry

Detailed instructions on navigating and using all the platform's features.

Manual on registering at ClinicalTrials.gov

A Russian-language guide with instructions on registering a study, managing the application, and examples of registering studies with various designs.

List of alternative foreign registries

A list of other international platforms for registering studies, with a description of each.

About the project

Publication bias in medicine and a plan to minimize the risks

Artur Rubenovich Navasardyan

Director of NIAEM, MD, PhD, cardiologist, senior lecturer at the Department of Clinical Epidemiology and Evidence-Based Medicine, National Medical Research Center for Therapy and Preventive Medicine (NMRC TPM)

Publishing a study

A negative result
also saves lives

Join the community of researchers. Find registered protocols and create new studies.

Questions

  • The tendency to publish primarily studies with statistically significant results. As a result, the body of accumulated data is skewed in favor of "positive" studies, while work with negative results often remains unpublished. This leads to the efficacy and safety profiles of any interventions being rated deliberately higher than they actually are. This tendency has a number of negative consequences for patients, the medical community, the healthcare system as a whole, and pharmaceutical companies. For the latter, publication bias also carries reputational and financial risks.

  • For this purpose, registration guidelines have been developed on the ClinicalTrials.gov website. A Russian-language registry of prospective studies, ClinicalStudy.RU, and a guide to using it have also been created. In addition, a list of other international registries has been prepared.

  • When enrolling in a research program, a patient signs an informed consent form stating that the results obtained will be used in the interest of other patients. The absence of a publication devalues the participation and the risks to which the patient was exposed as a result of taking part in the study.

  • Failing to publish results leads to the duplication of studies and the inefficient use of scientific resources. Entire teams spend time re-confirming a null hypothesis that has already been proven.

  • Any study involves significant financial costs: developing the protocol, maintaining documentation, the work of the research team, statistical analysis, and data processing. If the results of such studies are not published, the resources of the healthcare system are used irrationally and do not bring the expected benefit.

  • There are documents according to which any prospective clinical study must be registered in a registry of clinical studies and subsequently published. Registration is an integral part of the scientific process: it increases the transparency of studies, reduces the risk of data manipulation, and decreases publication bias.

Services

Evidence-based medicine in practice

Medical universities and departments

Scientific and methodological programs for developing research competencies.
Learn more

Key areas

evidence-based medicine methodology
study design
critical appraisal of publications
biostatistics
manuscript preparation

Pharmaceutical companies

Expert support at every stage: from regulatory strategy to communicating the value of a drug.
Learn more

Key areas

RWE/RWD
medical registries
regulatory strategies in the EAEU
medical marketing materials
webinars on Doclub.tv

Co-investigators and early-career researchers

Help with statistical processing, writing articles, and methodological support for studies.
Learn more

Key areas

data analysis
consultations
data validation
protocol preparation

Clinics and medical centers

Tools for improving the quality of medical care and operational efficiency.
Learn more

Key areas

optimization of patient routing
patient attrition analysis
improving treatment adherence
legal safety

Receive announcements of new studies, expert articles, invitations to webinars, and materials on evidence-based medicine.